Dikmen Zeliha Gunnur, Pinar Asli, Akbiyik Filiz
Hacettepe University Faculty of Medicine, Department of Medical Biochemistry and Hacettepe University Hospitals, Clinical Pathology Laboratory, Ankara, Turkey.
Biochem Med (Zagreb). 2015 Oct 15;25(3):377-85. doi: 10.11613/BM.2015.037. eCollection 2015.
The emergency laboratory in Hacettepe University Hospitals receives specimens from emergency departments (EDs), inpatient services and intensive care units (ICUs). The samples are accepted according to the rejection criteria of the laboratory. In this study, we aimed to evaluate the sample rejection ratios according to the types of pre-preanalytical errors and collection areas.
The samples sent to the emergency laboratory were recorded during 12 months between January to December, 2013 in which 453,171 samples were received and 27,067 specimens were rejected.
Rejection ratios was 2.5% for biochemistry tests, 3.2% for complete blood count (CBC), 9.8% for blood gases, 9.2% for urine analysis, 13.3% for coagulation tests, 12.8% for therapeutic drug monitoring, 3.5% for cardiac markers and 12% for hormone tests. The most frequent rejection reasons were fibrin clots (28%) and inadequate volume (9%) for biochemical tests. Clotted samples (35%) and inadequate volume (13%) were the major causes for coagulation tests, blood gas analyses and CBC. The ratio of rejected specimens was higher in the EDs (40%) compared to ICUs (30%) and inpatient services (28%). The highest rejection ratio was observed in neurology ICU (14%) among the ICUs and internal medicine inpatient service (10%) within inpatient clinics.
We detected an overall specimen rejection rate of 6% in emergency laboratory. By documentation of rejected samples and periodic training of healthcare personnel, we expect to decrease sample rejection ratios below 2%, improve total quality management of the emergency laboratory and promote patient safety.
哈杰泰佩大学医院的急诊实验室接收来自急诊科、住院部和重症监护病房(ICU)的标本。样本根据实验室的拒收标准进行接收。在本研究中,我们旨在根据分析前误差类型和采集区域评估样本拒收率。
2013年1月至12月的12个月期间,记录送往急诊实验室的样本,共接收453,171个样本,其中27,067个标本被拒收。
生化检测的拒收率为2.5%,全血细胞计数(CBC)为3.2%,血气分析为9.8%,尿液分析为9.2%,凝血检测为13.3%,治疗药物监测为12.8%,心脏标志物为3.5%,激素检测为12%。生化检测最常见的拒收原因是纤维蛋白凝块(28%)和样本量不足(9%)。凝块样本(35%)和样本量不足(13%)是凝血检测、血气分析和CBC的主要原因。急诊科的拒收标本比例(40%)高于重症监护病房(30%)和住院部(28%)。在重症监护病房中,神经内科重症监护病房的拒收率最高(14%),在住院科室中,内科住院部的拒收率最高(10%)。
我们在急诊实验室检测到总体标本拒收率为6%。通过记录拒收样本并对医护人员进行定期培训,我们期望将样本拒收率降至2%以下,改善急诊实验室的全面质量管理并促进患者安全。